[1]付彬彬,王文芳,叶婷婷,等.血清HMGB1及PCT水平检测对新生儿坏死性小肠结肠炎诊断和病情评估的价值[J].现代检验医学杂志,2021,36(06):87-89.[doi:10.3969/j.issn.1671-7414.2021.06.018]
　FU Bin-bin,WANG Wen-fang,YE Ting-ting,et al.Value of Serum HMGB1 and PCT Levels in Diagnosis and Evaluation of Neonatal Necrotizing Enterocolitis[J].Journal of Modern Laboratory Medicine,2021,36(06):87-89.[doi:10.3969/j.issn.1671-7414.2021.06.018]
点击复制

血清HMGB1及PCT水平检测对新生儿坏死性小肠结肠炎诊断和病情评估的价值()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第36卷
期数:
2021年06期
页码:
87-89
栏目:
论　著
出版日期:
2021-12-15

文章信息/Info

Title:
Value of Serum HMGB1 and PCT Levels in Diagnosis and Evaluation of Neonatal Necrotizing Enterocolitis
文章编号:
1671-7414（2021）06-087-04
作者:
付彬彬; 王文芳; 叶婷婷; 韩燕媚; 邱小翠
（海口市妇幼保健院检验科，海口 570100）
Author(s):
FU Bin-bin;  WANG Wen-fang;  YE Ting-ting;  et al
（Department of Clinical Laboratory，Haikou Maternal and Child Health Hospital, Haikou 570100，China）
关键词:
新生儿; 坏死性小肠结肠炎; 高迁移率族蛋白B1; 降钙素原
分类号:
R725.7；R446.112
DOI:
10.3969/j.issn.1671-7414.2021.06.018
文献标志码:
A
摘要:
目的　探讨血清高迁移率族蛋白B1（high mobility group box protein 1, HMGB1）及降钙素原（procalcitonin, PCT）水平对新生儿坏死性小肠结肠炎（necrotizing enterocolitis, NEC）诊断和病情评估的价值。方法　选取2017年1月～2020年3月海口市妇幼保健院收治的75例新生儿 NEC作为病例组和60例健康新生儿作为对照组。75例NEC新生儿根据修正Bell分期分为Ⅰ期（n=28），Ⅱ期（n=37）和Ⅲ期（n=10），根据75例患儿30天的预后情况，将其分为存活组（n=58）和死亡组（n=17）。对照组于出生3天后、病例组于治疗前检测血清HMGB1及PCT水平变化。应用ROC曲线分析血清HMGB1及PCT水平对新生儿NEC诊断及病情评估的价值。结果　病例组血清HMGB1（15.60±4.85 μg/L vs 3.18±1.14 μg/L）及PCT（1.74±0.92ng/ml vs 0.03±0.01 ng/ml）水平明显高于对照组（t=13.628，10.427，P<0.05）。死亡组血清HMGB1（24.50±7.13 μg/L vs 9.24±3.18 μg/L）及PCT（3.02±1.35ng/ml vs 0.85±0.38 ng/ml）水平明显高于存活组（t=16.217，12.308，P<0.05），差异均有统计学意义。Ⅱ～Ⅲ期血清HMGB1（20.16±6.37 μg/L vs 10.54±3.20 μg/L）及PCT（2.85±1.30 ng/ml vs 0.94±0.42 ng/ml）水平均明显高于Ⅰ期，差异均有统计学意义（t=8.263，7.624，均P<0.05）。ROC曲线分析显示，HMGB1及PCT两项联合诊断新生儿NEC的曲线下面积（0.872，95%CI：0.814～0.930）最大，其敏感度和特异度较高，分别为87.4%和83.5%。HMGB1及PCT两项联合预测新生儿NEC死亡的曲线下面积（0.893，95%CI：0.836～0.952）最大，其敏感度和特异度较高，分别为89.0%和86.4%。结论　血清HMGB1及PCT水平在新生儿NEC中明显升高，且与患儿病情严重程度相关，两项联合检测对新生儿NEC诊断及病情评估具有一定价值。
Abstract:
Objective　To explore the value of serum high mobility group box protein B1 (HMGB1) and procalcitonin (PCT) levels in the diagnosis and disease assessment of neonatal necrotizing enterocolitis (NEC). Methods　The 75 cases of neonatal NEC admitted to Haikou Maternal and Child Health Hospital from January 2017 to March 2020 were selected as case group and 60 healthy neonates as control group. 75 NEC neonates were divided into I stage (n=28), II stage (n=37) and III stage (n=10) according to modified bell stage. According to the prognosis of 75 neonates at 30 days, they were divided into survival group (n=58) and death group (n=17). The changes of serum HMGB1 and PCT levels were detected before treatment in the case group and three days after birth in the control group. The value of serum HMGB1 and PCT levels in diagnosis and disease assessment of neonatal NEC was analyzed by ROC curve. Results　The serum levels of HMGB1（15.60±4.85μg/L vs 3.18±1.14 μg/L） and PCT（1.74±0.92ng/ml vs 0.03±0.01ng/ml） in the case group were significantly higher than those in the control group (t=13.628, 10.427, P <0.05). The serum levels of HMGB1（24.50±7.13μg/L vs 9.24±3.18 μg/L） and PCT（3.02±1.35ng/ml vs 0.85±0.38 ng/ml） in the death group were significantly higher than those in the survival group (t=16.217, 12.308, P<0.05), the differences were statistically significant, respectively. The serum levels of HMGB1（20.16±6.37μg/L vs 10.54±3.20 μg/L） and PCT（2.85±1.30ng/ml vs 0.94±0.42ng/ml） in II-III stage were significantly higher than those in I stage, the difference was statistically significant (t=8.263, 7.624, all P<0.05). ROC curve analysis showed that the area under the curve (0.872, 95% CI: 0.814~0.930) of the combined diagnosis of HMGB1 and PCT for neonatal NEC was the largest, with a higher sensitivity and specificity of 87.4% and 83.5%. The area under the curve (0.893, 95% CI: 0.836~0.952) of HMGB1 and PCT combined to predict neonatal NEC death was the largest, with a higher sensitivity and specificity of 89.0% and 86.4%. Conclusion　Serum levels of HMGB1 and PCT were significantly increased in neonatal NEC, and were related to the severity of the disease. The combined detection of HMGB1 and PCT was valuable for the diagnosis and disease assessment of neonatal NEC.

参考文献/References:

[1] BELLODAS SANCHEZ J, KADROFSKE M.Necrotizing enterocolitis[J]. Neurogastroenterology andMotility, 2019, 31(3): e13569.
[2] 李禄全, 郭露, 张忠垚, 等. 新生儿坏死性小肠结肠炎诊断及内科治疗进展[J]. 中华实用儿科临床杂志,2020, 35 (11): 810-814.LI Luquan, GUO Lu, ZHANG Zhongyao, et al.Advance of diagnosis and medical treatment forneonatal necrotizing enterocolitis [J]. ChineseJournal of Applied Clinical Pediatrics, 2020, 35 (11):810-814.
[3] TERRIN G, STRONATI L, CUCCHIARA S, et al.Serum markers of necrotizing enterocolitis: a systematicreview[J]. Journal of Pediatric Gastroenterology andNutrition, 2017, 65(6): E120-E132.
[4] GOLDSTEIN GREGORY P， SYLVESTER KARLG. Biomarker discovery and utility in necrotizingenterocolitis[J]. Clinics in Perinatology, 2019, 46(1):1-17.
[5] 中国医师协会新生儿科医师分会循证专业委员会. 新生儿坏死性小肠结肠炎临床诊疗指南(2020)[J]. 临床医学研究与实践，2021, 23 (1): 1-11.Evidence-Based Medicine Group, NeonatologistSociety, Chinese Medical Doctor Association. Clinicalguidelines for the diagnosis and treatment of neonatalnecrotizing enterocolitis (2020) [J]. Chinese Journal ofContemporary Pediatrics, 2021, 23 (1): 1-11.
[6] DUKLESKA K, DEVIN C L, MARTIN A E, et al.Necrotizing enterocolitis totalis: High mortality in theabsence of an aggressive surgical approach[J]. Surgery,2019, 165(6): 1176-1181.
[7] 吕志宝，盛庆丰．新生儿坏死性小肠结肠炎的病因与诊治研究进展[J]．临床小儿外科杂志, 2019,18 (5):352-355.L? Zhibao, SHENG Qingfeng. Advances in theetiology, diagnosis and treatment of neonatalnecrotizing enterocolitis [J]. Journal of ClinicalPediatric Surgery, 2019,18 (5): 352-355.
[8] YU Renqiang, JIANG Shanyu, TAO Yaqin, etal. Inhibition of HMGB1 improves necrotizingenterocolitis by inhibiting NLRP3 via TLR4 andNF-κB signaling pathways[J]. Journal of CellularPhysiology, 2019, 234(8): 13431-13438.
[9] BASSETTI M, RUSSO A, RIGHI E, et al. Role ofprocalcitonin in bacteremic patients and its potentialuse in predicting infection etiology[J]. Expert Reviewof Anti-Infective Therapy, 2019, 17(2): 99-105.
[10] ZHANG Han, CHEN Jiaping, WANG Yan, et al.Predictive factors and clinical practice profile forstrictures post- necrotising enterocolitis[J]. Medicine,2017, 96(10): e6273.
[11] 黄玲, 廖春. 血清血管活性肠肽、降钙素原及血清淀粉样蛋白A 在儿童肠炎鉴别诊断中的价值[J]．中国临床医生杂志, 2021, 49 (4): 484-487.HUANG Ling, LIAO Chun. The value of serumvasoactive intestinal peptide, procalcitonin and serumamyloid A in the differential diagnosis of enteritis inchildren [J]. Chinese Journal for Clinicians, 2021, 49(4): 484-487.
[12] 郑泽兵，刘远梅，张帆，等．降钙素原、白细胞介素-6、C 反应蛋白在新生儿坏死性小肠结肠炎手术时机选择中的应用研究[J]．临床小儿外科杂志，2019,18 (5):361-367.ZHENG Zhebing, LIU Yuanmei, ZHANG Fan, etal. Applicable value of operative opportunity forprocalcitonin, interleukin-6 and C-reactive proteinin neonatal necrotizing enterocolitis [J]. Journal ofClinical Pediatric Surgery, 2019,18 (5): 361-367.
[13] 罗若谷，赵静儒，徐泉，等．高迁移率族蛋白B1联合肠型脂肪酸结合蛋白对新生儿坏死性小肠结肠炎的诊断价值[J]. 中华普通外科学文献（电子版）,2020, 14 (2): 111-114.LUO Ruogu, ZHAO Jingru, XU Quan, et al. Diagnosticvalue of high mobility group protein B1 combinedwith intestinal fatty acid binding protein in neonatalnecrotizing enterocolitis [J]. Chinese Archives ofGeneral Surgery(Electronic Edition), 2020, 14 (2): 111-114.
[14] 汪莉, 倪申旺, 朱克然, 等．C- 反应蛋白、降钙素原在新生儿坏死性小肠结肠炎患儿的水平变化及临床意义[J]. 中国当代儿科杂志, 2018, 20 (10): 825-830.WANG Li, Ni Shenwang, ZHU Keran, et al. Changesin C-reactive protein and procalcitonin levels inneonates with necrotizing enterocolitis and their clinicalsignificance [J]. Chinese Journal of ContemporaryPediatrics, 2018, 20 (10): 825-830.
[15] 姜燕，任荣．新生儿坏死性小肠结肠炎血清I-FABP,PCT, CRP, IL-8 水平变化及临床意义[J]. 海南医学,2021, 32 (6): 763-765．JIANG Yan, REN Rong. Changes of serum intestinalfatty acid binding protein, procalcitonin, C-reactiveprotein, interleukin-8 levels in neonatal necrotizingenterocolitis and its clinical significance [J]. HainanMedical Journal, 2021, 32 (6): 763-765．

相似文献/References:

[1]杨 丽,阎丽华,丁 伟,等.新生儿ABO血型不合溶血病临床及实验室结果分析研究[J].现代检验医学杂志,2015,30(04):158.[doi:10.3969/j.issn.1671-7414.2015.04.049]
　YANG Li,YAN Li-hua,DING Wei,et al.Clinical and Experimental Analysis about ABO Hemolytic Disease of the Newborn in Qingdao[J].Journal of Modern Laboratory Medicine,2015,30(06):158.[doi:10.3969/j.issn.1671-7414.2015.04.049]
[2]白 静,侯兴宁,兰海琴.新生儿凝血危急值在临床实践中的应用以及正常参考范围的调查分析[J].现代检验医学杂志,2017,32(01):150.[doi:10.3969/j.issn.1671-7414.2017.01.042]
　BAI Jing,HOU Xing-ning,LAN Hai-qin.Critical Values of Neonatal Coagulation in Clinical Practice and the Investigation of Normal Reference Range[J].Journal of Modern Laboratory Medicine,2017,32(06):150.[doi:10.3969/j.issn.1671-7414.2017.01.042]
[3]刘震忠,吴凤琪,闫 静,等.2015～2016年天津地区新生儿TORCH血清学筛查及感染特点[J].现代检验医学杂志,2017,32(04):133.[doi:10.3969/j.issn.1671-7414.2017.04.038]
　LIU Zhen-zhong,WU Feng-qi,YAN Jing,et al.TORCH Serological Screening and Infection Characteristic in Neonate in Tianjin Area[J].Journal of Modern Laboratory Medicine,2017,32(06):133.[doi:10.3969/j.issn.1671-7414.2017.04.038]
[4]王　蓉,陈紫茹,唐露丹,等.广州市第一人民医院新生儿病区金黄色葡萄球菌毒力基因分布分析[J].现代检验医学杂志,2019,34(06):63.[doi:10.3969 ／ j.issn.1671-7414.2019.06.015]
　WANG Rong,CHEN Zi-ru,TANG Lu-dan,et al.Analysis of Virulence Gene Distribution of Staphylococcus Aureus in Neonatal Disease Area from the First People’s Hospital of Guangzhou[J].Journal of Modern Laboratory Medicine,2019,34(06):63.[doi:10.3969 ／ j.issn.1671-7414.2019.06.015]
[5]黄卫彤,朱茂灵,覃卫娟,等.广西壮族自治区南宁市新生儿GJB2 致聋基因的携带研究[J].现代检验医学杂志,2020,35(01):13.[doi:10.3969/j.issn.1671-7414.2020.01.004]
　HUANG Wei-tong,ZHU Mao-ling,QIN Wei-juan,et al.Study on the Carrying of GJB2 Deafness Gene in Newborns of Nanning City[J].Journal of Modern Laboratory Medicine,2020,35(06):13.[doi:10.3969/j.issn.1671-7414.2020.01.004]
[6]钟锦平,彭维林,傅清流,等.福建泉州地区新生儿氨基酸代谢障碍的筛查结果分析[J].现代检验医学杂志,2020,35(04):41.[doi:10.3969/j.issn.1671-7414.2020.04.010]
　ZHONG Jin-ping,PENG Wei-lin,FU Qing-liu,et al.Retrospective Analysis of the Neonatal Screening Results of Amino Acid Disorders in Quanzhou Region, Fujian Province[J].Journal of Modern Laboratory Medicine,2020,35(06):41.[doi:10.3969/j.issn.1671-7414.2020.04.010]
[7]宋婷阁,张鹏举,耿　彪,等.新生儿急性呼吸窘迫综合征患者血清miR-183-5p的表达及与IL-1β，IL-6和TNF-α水平的相关性[J].现代检验医学杂志,2021,36(05):55.[doi:10.3969/j.issn.1671-7414.2021.05.012]
　SONG Ting-ge,ZHANG Peng-ju,GENG Biao,et al.Expression of Serum miR-183-5p in Patients with Neonatal Acute RespiratoryDistress Syndrome and Its Correlation with IL-1 β, IL-6 and TNF-α[J].Journal of Modern Laboratory Medicine,2021,36(06):55.[doi:10.3969/j.issn.1671-7414.2021.05.012]
[8]祁秋霞,吴良宇,张文雅.早产儿坏死性小肠结肠炎患者血清miR-21-3p 和miR-22-3p 水平表达与病情严重程度的分析研究[J].现代检验医学杂志,2023,38(06):59.[doi:10.3969/j.issn.1671-7414.2023.06.011]
　QI Qiuxia,WU Liangyu,ZHANG Wenya.Study on the Relationship between Serum miR-21-3p and miR-22-3p Expression Levels and Severity of Necrotizing Enterocolitis in Premature Infants[J].Journal of Modern Laboratory Medicine,2023,38(06):59.[doi:10.3969/j.issn.1671-7414.2023.06.011]
[9]陈小冰,张雪梅,陈求凝,等.新生儿坏死性小肠结肠炎患者血清 IL-12 及 IL-17 水平检测及临床意义[J].现代检验医学杂志,2020,35(06):179.[doi:doi:10.3969/j.issn.1671-7414.2020.06.044]
　CHEN Xiao-bing,ZHANG Xue-mei,CHEN Qiu-ning,et al.Detection and Clinical Significance of Serum IL-12 and IL-17 Levels inNeonatal Necrotizing Enterocolitis[J].Journal of Modern Laboratory Medicine,2020,35(06):179.[doi:doi:10.3969/j.issn.1671-7414.2020.06.044]

备注/Memo

备注/Memo:
作者简介：付彬彬（1981-）,女，本科，主管检验师，主要从事临床检验诊断研究，E-mail: qq30234650@163.com。
更新日期/Last Update: 1900-01-01